EXANE DERIVATIVES - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 240 filers reported holding NEOGENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q2 2022$1,230,000
-95.5%
151
-93.2%
0.00%
-87.5%
Q1 2022$27,056,000
-78.9%
2,227
-40.8%
0.01%
-74.2%
Q4 2021$128,287,000
-23.6%
3,760
+8.0%
0.03%
-22.5%
Q3 2021$168,014,000
-8.4%
3,483
-14.2%
0.04%
-4.8%
Q2 2021$183,463,000
-29.3%
4,059
-24.6%
0.04%
-43.2%
Q1 2021$259,466,000
-37.0%
5,380
-29.7%
0.07%
-38.8%
Q4 2020$412,018,0007,6530.12%
Other shareholders
NEOGENOMICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 396,327$8,109,0006.56%
Cowen Prime Services LLC 584,766$11,964,0006.20%
1492 Capital Management LLC 269,488$5,514,0004.67%
First Light Asset Management, LLC 1,604,611$32,830,0004.27%
PERKINS CAPITAL MANAGEMENT INC 264,650$5,415,0003.56%
FALCON POINT CAPITAL, LLC 219,992$4,501,0002.45%
Granite Investment Partners, LLC 1,764,090$36,093,0002.05%
Ranger Investment Management 1,209,535$24,747,0001.79%
EMERALD ADVISERS, LLC 1,878,901$38,442,0001.56%
EMERALD MUTUAL FUND ADVISERS TRUST 1,875,759$38,378,0001.54%
View complete list of NEOGENOMICS INC shareholders